|
Product complaint # (b)(4).Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.The following information was requested, but unavailable: what was used to complete the procedure? attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Did the fixation feature break pre-op or intra-op? a manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.This is a combination product, and the event has been reviewed for both the suture and the triclosan.Ingredient(s) ¿ triclosan, dosage form ¿ suture/solid/parenteral, strength ¿ = 2360 ¿g/m.Information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
It was reported that a patient underwent an unknown procedure on (b)(6) 2022 and barbed suture was used.During the procedure the fixation tab was broken.It is unknown whether the event occurred before use or during use.As for the actual product, it is in pretty clean condition, so it is possible that the issue was found after the package was opened.No adverse patient consequences were reported.Additional information was requested.
|
|
Product complaint # (b)(4).Date sent to the fda: 3/11/2022.This is a combination product, and the event has been reviewed for both the suture and the triclosan.This report is being submitted pursuant to the provisions of 21 cfr, part 803, part 4 subpart b.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested, the following was obtained: did the fixation feature break pre-op or intra-op? : intra-op.No further information will be provided.H3 investigational narrative: the product was returned to ethicon inc for evaluation.Ethicon inc conducted a visual inspection of the sample returned.Visual analysis of the returned product revealed that one opened sample product code sxpp1a402 was received for evaluation.Upon visual inspection of the returned sample, the suture barbs were to be damaged at the tips, in addition the fixation tab was observed to have one side broken.After further evaluation of the fixation tab crimping marks were observed on the tab possibly from a surgical device.It should be noted that a 100% inspection is perform via automotive vision system to ensure the tab is present and complete during manufacturing.As with any device, care should be taken to avoid damage to the strand when handling.Avoid the crushing or crimping action of the surgical instruments, such as needle holders and forceps.To seat the fixation tab; pull the device through the tissue to gently seat the fixation tab against the tissue.The fixation tab should be seated above the tissue plane and be visible.Do not exert additional force on the fixation tab.As part of our quality process, the manufacturing records of this lot-serial number were reviewed, and the manufacturing standards were met prior to the release of this batch.As part of ethicon quality process, all devices are manufactured, inspected, and released to approved specifications.Additional complaint information monitoring for potential safety signals is conducted through complaint trending as part of post-market surveillance.Trade name - irgacare®, active ingredient(s) ¿ triclosan, dosage form ¿ suture/solid/parenteral, strength ¿ = 2360 g/m.
|